Hospital Universitario Central de Asturias -ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2023

  1. Lymphoproliferative disorders after renal transplantation along 2 decades: A large longitudinal study of 21,546 recipients

    Nefrologia, Vol. 43, Núm. 4, pp. 427-434

  2. Update of the recommendations on the management of the SARS-CoV-2 coronavirus pandemic (COVID-19) in kidney transplant patients

    Nefrologia, Vol. 43, Núm. 5, pp. 531-545

2022

  1. Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients

    Transplantation, Vol. 106, Núm. 7, pp. 1430-1439

2020

  1. Recommendations on management of the SARS-CoV-2 coronavirus pandemic (Covid-19) in kidney transplant patients

    Nefrologia, Vol. 40, Núm. 3, pp. 265-271

2019

  1. Direct-Acting Antivirals for the Treatment of Kidney Transplant Patients with Chronic Hepatitis C Virus Infection in Spain: A Long-Term Prospective Observational Study

    Transplantation Direct, Vol. 5, Núm. 12

2015

  1. Medium-Term Renal Function in a Large Cohort of Stable Kidney Transplant Recipients Converted from Twice-Daily to Once-Daily Tacrolimus

    Transplantation Direct, Vol. 1, Núm. 7, pp. E24

2013

  1. High incidence of delayed graft function in HIV-infected kidney transplant recipients

    Transplant International, Vol. 26, Núm. 9, pp. 893-902

2011

  1. Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients

    American Journal of Transplantation, Vol. 11, Núm. 9, pp. 1965-1971